Join
Live feed
·
INSIDERFilingvia Quantisnow
Dianthus Therapeutics Inc. logo

EVP, Head of R&D Randhawa Simrat exercised 23,124 shares at a strike of $20.63 and sold $2,460,690 worth of shares (23,124 units at $106.41) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNTH (Dianthus Therapeutics Inc.) and more on Quantisnow.